Kerala Ayurveda P/E Ratio
Kerala Ayurveda (KERALAYUR) P/E ratio is not applicable — EPS (TTM) ₹-11.60, 2 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has reported losses in the last 2 quarters. P/E ratio is not applicable during loss periods.
Consecutive Loss Quarters: 2
Current EPS: ₹-11.60
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -7.23 | -6 | Loss |
| Mar 2025 | -13.68 | -15 | Loss |
| Jun 2025 | 1.92 | 2 | Profit |
| Dec 2025 | -3.69 | -5 | Loss |
| Sept 2024 | 3.10 | 4 | Profit |
| Mar 2024 | 0.50 | 1 | Profit |
| Jun 2024 | 0.33 | 1 | Profit |
| Dec 2024 | -2.40 | -3 | Loss |
Healthcare Peers with Valid P/E Ratios — KERALAYUR Comparison
Healthcare sector average P/E 53.61, median 27.37 — KERALAYUR excluded (negative EPS).
Sector Average PE
53.61
Sector Median PE
27.37
Lowest PE
1.03
Profitable Companies
193
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.71 | ₹71 | Low |
| Shelter Pharma | SHELTER | 6.75 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹23 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹74 | Low |
| Par Drugs & Chemical | PAR | 8.21 | ₹114 | Low |
| Medicamen Organics | MEDIORG | 8.76 | ₹35 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Kerala Ayurveda share price chart.
- Check KERALAYUR market value to track the company's total market size over time.
- Compare with Kerala Ayurveda value estimation to assess whether the stock is under or overvalued.